307 results about "Female patient" patented technology

A woven mesh is provided for supporting tissue or an organ within a female patient's pelvis, and a method for using the same. The mesh includes a central portion having a width, a length, first and second ends, and first and second side edges, and first and second wing portions extending from the first and second ends of the central portion respectively. The first and second wing portions each have a width, a length, and first and second peripheral edges. The width of the wing portions are each greater than the width of the central portion, and when positioned within the female patient, the central portion is positioned below and supports the tissue or organ. A mesh is also provided having woven fibers with voids therebetween, and having a central portion and first and second ends. The average size of the voids at least in the central portion is at least 25–50 mm², and when positioned within the patient, the central portion is positioned below and supports the tissue or organ.

A physiological sensor device is attachable to the skin of a person for collecting physiological signals generated by the person's body. The device includes a flexible front layer made of a material that does not conduct electricity and a flexible back layer made of a material that does not conduct electricity. A flexible intermediate layer made of a material that does not conduct electricity is sandwiched between and fixed to the front layer and the back layer. Electrodes and electrical conductors are fixed to a back side of the intermediate layer. Each of the electrodes is attached to one of the electrical conductors and all of the electrical conductors are attached to a single common connector that protrudes through a portal in the front layer. A conductive gel pad is adhered to and aligned with each of the electrodes and protrudes through a portals in the back layer to contact the skin of a person when the physiological sensor device is attached to the skin of a person. Each layer of the physiological sensor device has, when attached to a standing person's chest, a vertically extending portion with a horizontally extending portion located at a lower end of the vertically extending portion to give the physiological sensor device a shape like an inverted T. The vertically extending portion is intended to overly a person's sternum and is sized to comfortably fit either a male or female patient.

An anterior implant adapted to treat central and lateral cystoceles present in a female patient includes laterally extending stabilizing straps for supporting the implant between the patient's bladder and vagina independently of the patient's arcus tendineous fascia pelvis. Rectocele and hysterocele repairs can be carried out using a single posterior implant which, like the anterior implant, is provided with laterally extending stabilizing straps for supporting the implant between the patient's rectum and vagina.

The endometriosis treatment protocol provides for administering to a female patient in need of treatment for endometriosis a pharmaceutical composition in a form suitable for vaginal or rectal delivery having a pharmaceutically effective amount of an aromatase inhibitor, which may be either a steroid or non-steroidal. The pharmaceutical composition may be formed as a vaginal suppository, a rectal suppository, a vaginal gel, a rectal gel, a vaginal cream or a rectal cream. The pharmaceutical composition may optionally have pharmaceutically effective amounts of progesterone and calcitriol, and may be administered in combination with an oral COX-2 inhibitor. Alternatively, the pharmaceutical composition comprises an aromatase inhibitor administered vaginally or rectally and is administered in combination with oral calcitriol and the oral COX-2 inhibitor. The aromatase inhibitor is either steroidal or non-steroidal.

This invention relates to devices targeted to resolving various conditions of a female patient in need thereof, the conditions being female sexual dysfunction and urinary incontinence. The present disclosure provides for a device which incorporates a variety of elements in an effort to treat certain conditions of a female individual in need thereof. Optionally, the device of the present invention may be used as a prophylactic measure to prevent a condition selected from the group consisting of female sexual dysfunction and urinary incontinence.

The present disclosure is related to an intrauterine system (insertion device) including an intrauterine device (IUD), an insertion device or applicator for inserting the IUD into the cervix of a female patient, methods related to the insertion procedure, and methods of manufacture for the insertion device.

An occluding device is disclosed for occluding a female patient's uterine arteries which have unsymmetrical anatomy with respect to the patient's uterine cervix. The occluding device has a pair of pivotally connected occluding members, with at least one of the occluding member having a movable occluding element on a distal shaft section of the occluding member. The position and orientation of the occluding elements on the distal shaft sections may be adjusted by operative members on the proximal shaft sections of the occluding members to accommodate for asymmetrical uterine artery anatomy. The occluding elements have pressure applying surfaces with one or more blood flow sensors such as Doppler chips which help the physician to better identify the uterine artery and to monitor blood flow therein. A tenaculum-like guiding element configured to be secured within the patient's uterine cervix, may be provided to guide the occluding device to the patient's cervix.

A method and apparatus of occluding a lumen of a body cavity, more preferably, the lower uterine segment and/or cervix of a female patient is provided that results in a significant reduction or complete elimination of uterine bleeding, thereby providing a treatment option for conditions such as menorrhagia or dysmenorrhea.

A device is provided herein for locating a breast of a female patient. In one embodiment, the locating device is adapted to be inserted into an opening within a patient table. The locating device is further adapted with different sizes and shapes, and thus, can be adapted to various breast shapes. In one embodiment, the device is provided with an RFID transponder for identifying the particular locating device being used. The RFID transponder enables data about the locating device to be automatically recorded along with the image data. This enables the shape of the locating device to be taken into account when evaluating an image. Furthermore, the RFID transponder ensures that a locating device of the same shape is used for subsequent exposures of a patient's breast, so that the exposures remain comparable.

An apparatus for use in connection with an endoscopic surgery comprises an elongated body adapted to be placed at least partially in the vagina of a female patient partially passing through the wall of the vagina such that an end portion of said elongated element is introduced into rectouterine pouch; the elongated body comprises at least an attachment means for accommodating at least a part of at least a surgical instrument comprising an end portion adapted to be received inside the vagina, the surgical instrument and the apparatus are movable to each other. An endobag having an elongated port is provided through the vagina into the pelvis. A method for use in a pelvic or peritoneal surgery is provided wherein at least an elongated end portion of a surgical instrument is provided in the cavity of the uterus through the vagina of a female patient such that the uterus can be repositioned by manipulating the surgical instrument and an incision is performed on the vaginal wall for accessing to the rectouterine pouch, a flexible element is provided in pelvis wherein the flexible element is looped around the uterus such that the flexible element encircles the uterus.

An X-ray machine for examining a breast of a female patient has a CT scanner attached to a patient's table. An instrument holder that is adapted to be moved to be located underneath a gantry of the CT scanner is provided with a positioning unit for positioning an instrument for examining or operating close to the breast. An exact position of the instrument holder relative to the gantry or the breast to be examined can be determined with a measuring system. Thereby, it is possible to position an examining or surgical intervention instrument extremely precisely.

The invention is a post-operative binder designed primarily for female patients made of relatively elastic and padded material. The present invention is designed to put pressure on the Phannanstiel incisional area to prevent swelling through the use of a primary fastener and cross straps. Cross straps are fixedly attached to the midline section of the binder and removably attach to the sides of the binder at an angle to apply the appropriate pressure to the incisional area. The invention is designed with pockets to accommodate hold hot or cold packs in the incisional area, pain relief devices, sandbags or other hard or soft support structures to apply additional pressure, or drainage receptacles.

Compounds of structural formula (I) are disclosed as useful for modulating the androgen receptor (AR) in a tissue selective manner in a patient in need of such modulation, and in particular for antagonizing AR in the prostate of a male patient or in the uterus of a female patient and agonizing AR in bone and/or muscle tissue. These compounds are useful in the treating conditions caused by androgen deficiency or which can be ameliorated by androgen administration, including: osteoporosis, periodontal disease, bone fracture, bone damage following bone reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism, female sexual dysfunction, post-menopausal symptoms in women, atherosclerosis, hypercholesterolemia, hyperlipidemia, aplastic anemia and other hematopoietic disorders, pancreatic cancer, renal cancer, prostate cancer, arthritis and joint repair, alone or in combination with other active agents. In addition, these compounds are useful as pharmaceutical composition ingredients alone and in combination with other active agents.